Keyphrases
HIV Patients
100%
Indonesia
66%
Antiretroviral Therapy
66%
Indonesian
63%
Cytomegalovirus
59%
Multiple Sclerosis
45%
Tuberculous Meningitis
36%
Therapeutic Plasma Exchange
32%
South-East Asia
26%
Quality of Life
24%
Multiple Sclerosis Treatment
24%
Randomized Placebo-controlled Trial
21%
Polymorphism
19%
High Burden
18%
Cognitive Impairment
16%
Southeast Asian
15%
COVID-19
14%
Healthy Controls
14%
Carotid Intima-media Thickness (cIMT)
14%
T Cells
14%
Peripheral Neuropathy
14%
Natural Killer Cells
13%
CNS Infection
13%
Neuromyelitis Optic
13%
AIDS/HIV
13%
Aquaporin-4 (AQP4)
13%
Autoimmune Encephalitis
13%
CMV Seropositivity
13%
T Cell Subpopulations
13%
Consensus Recommendations
13%
Atorvastatin
13%
Neurological Diseases
13%
Subclinical Atherosclerosis
13%
Cerebrospinal Fluid
13%
Jakarta
11%
CD4 T Cells
11%
Early Detection
10%
Nave
10%
Clinical Presentation
10%
Neuropathy Screening
10%
HIV-associated Neurocognitive Disorders
10%
Stimulated Skin Wrinkling
9%
Immune Activation
9%
Referral Hospital
9%
Tryptophan Metabolism
9%
Etiology
9%
Exchange Service
9%
Psychosocial Outcomes
9%
Malaysia
9%
Autoimmune Disease
8%
Medicine and Dentistry
Human Immunodeficiency Virus
88%
Multiple Sclerosis
36%
Plasma Exchange
32%
Cytomegalovirus
31%
Antiretroviral Therapy
21%
Central Nervous System Infection
19%
Placebo
19%
Central Nervous System
17%
Tuberculous Meningitis
16%
Diseases
15%
Neuropathy
15%
Neurologic Disease
13%
Atorvastatin
13%
Atherosclerosis
13%
T Cell
11%
Quality of Life
10%
Patient Referral
9%
Drug Megadose
9%
Encephalitis
9%
Cross Sectional Study
8%
Cytomegalovirus Infection
8%
Nervous System Disorder
8%
Plasmapheresis
8%
Optic Nerve
8%
Headache
8%
Stavudine
7%
Cardiovascular System
7%
Intima-Media Thickness
7%
Skin Wrinkle
7%
Prospective Cohort Study
7%
Intracranial Tumor
7%
Brain Infection
7%
Cognitive Assessment
7%
Nerve Conduction Study
7%
Sensory Neuropathy
7%
Neuromyelitis Optica
7%
Disease
6%
Volumetry
6%
Systemic Lupus Erythematosus
6%
Natural Killer Cell
6%
Outcome Assessment
6%
T Lymphocyte Subpopulation
6%
Ro Antibody
6%
Peripheral Nervous System
6%
Rifampicin
6%
Cohort Analysis
6%
Retinal Blood Vessel
6%
Cell Population
6%
Nerve Function
6%
Phase III Trials
6%